Oral anticoagulation in patients with hypertrophic cardiomyopathy and non‐valvular atrial fibrillation in Japan

Oral anticoagulation in patients with hypertrophic cardiomyopathy and non‐valvular atrial fibrillation in Japan

Abstract Aims There are limited data to support direct oral anticoagulant (DOAC) use in patients with hypertrophic cardiomyopathy (HCM) and non‐valvular atrial fibrillation (NVAF). The current study investigated the safety and effectiveness of DOACs versus warfarin in patients in Japan. Methods This...

Full description

Saved in:
Bibliographic Details
Main Authors: Hiroaki Kitaoka, Robert Carroll, Natalie Eugene, Bruno Casaes Teixeira, Yukako Matsuo, Toru Kubo
Format: Article
Language:English
Published: Wiley 2025-02-01
Series:ESC Heart Failure
Subjects:
atrial fibrillation
hypertrophic cardiomyopathy
ischaemic stroke
direct oral anticoagulant
Online Access:https://doi.org/10.1002/ehf2.15039
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/ehf2.15039

Similar Items